PRI Drops Suit Against Top Two FCRF Staff; Gilden, Compton Accept “Partnership” Offers
In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt
NCI Amends FCRF RFP, Extends Deadline To Nov. 10
Caribbean Conference Reports Incidence Differences With U.S.
Malone Retires As NIH Deputy, Raub To Succeed Him
Eight Win ASCO Young Investigator Awards
Niccotine Reports As Aiding Metastasis
President, Congress, Cancer Letter Take Off
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- Did Vinay Prasad need to mention the Nazis to make a point on the U.S. pandemic response?
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies - Prasad: FDA has confused merely approving drugs with making the world a better place